Trending Topics

GE and Masimo Ink OEM deal

GE Healthcare will integrate Masimo’s Rainbow SET technology into its patient monitoring devices

Irvine, CA - GE Healthcare (NYSE:GE) and Masimo (NSDQ:MASI) inked a long-term deal that will see GE integrate Masimo’s Rainbow SET technology into many of its patient monitoring products.

The Masimo technology is designed to provide non-invasive and continuous measurement of multiple blood constituents, fluid responsiveness and other physiological parameters. That helps caregivers identify conditions such as low levels of blood oxygen, hemoglobin, and/or perfusion, as well as elevated levels of carbon monoxide and methemoglobin in the blood, abnormal pulse rates, and fluid responsiveness, according to a press release.

“Through our focused Monitoring Solutions division, GE Healthcare is committed to optimally collecting information from the patient’s body, and transforming it into meaningful intelligence for caregivers. Masimo’s suite of noninvasive and continuous Rainbow SET measurements will further enhance the point-of-care clinical intelligence benefits already offered in GE Healthcare’s patient monitors,” Matthias Weber, the division’s general manager, said in prepared remarks.

“GE Healthcare’s patient monitoring lines have a long history of innovative clinical measurements and system solutions that enhance patient care decisions. We are excited to announce this expansion of our partnership with GE Healthcare and are proud to work with them to incorporate rainbow SET measurements in their monitoring solutions to continue this tradition for the benefit of customers and the patients they serve,” added Rick Fishel, president of Masimo’s worldwide OEM business & corporate development.

About Masimo
Masimo is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors. A key medical technology innovator, Masimo is responsible for the invention of award-winning noninvasive technologies that are revolutionizing patient monitoring, including Masimo SET® pulse oximetry, Masimo rainbow® SET Pulse CO-Oximetry and new Masimo noninvasive and continuous total hemoglobin (SpHb®) monitoring technology.